Caseware UK (AP4) 2024.0.164 2024.0.164 2024-12-312024-12-31false2024-01-011Investment Company1truetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 11963976 2024-01-01 2024-12-31 11963976 2023-01-01 2023-12-31 11963976 2024-12-31 11963976 2023-12-31 11963976 c:Director2 2024-01-01 2024-12-31 11963976 d:CurrentFinancialInstruments 2024-12-31 11963976 d:CurrentFinancialInstruments 2023-12-31 11963976 d:CurrentFinancialInstruments d:WithinOneYear 2024-12-31 11963976 d:CurrentFinancialInstruments d:WithinOneYear 2023-12-31 11963976 d:ShareCapital 2024-12-31 11963976 d:ShareCapital 2023-12-31 11963976 d:RetainedEarningsAccumulatedLosses 2024-12-31 11963976 d:RetainedEarningsAccumulatedLosses 2023-12-31 11963976 c:OrdinaryShareClass1 2024-01-01 2024-12-31 11963976 c:OrdinaryShareClass1 2024-12-31 11963976 c:OrdinaryShareClass1 2023-12-31 11963976 c:FRS102 2024-01-01 2024-12-31 11963976 c:AuditExempt-NoAccountantsReport 2024-01-01 2024-12-31 11963976 c:FullAccounts 2024-01-01 2024-12-31 11963976 c:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 11963976 2 2024-01-01 2024-12-31 11963976 6 2024-01-01 2024-12-31 xbrli:shares iso4217:GBP xbrli:pure
Registered number: 11963976






NEUCLIB LIMITED

UNAUDITED
FINANCIAL STATEMENTS
INFORMATION FOR FILING WITH THE REGISTRAR
FOR THE YEAR ENDED 31 DECEMBER 2024

 
NEUCLIB LIMITED
REGISTERED NUMBER: 11963976

BALANCE SHEET
AS AT 31 DECEMBER 2024

2024
2023
Note
£
£

Fixed assets
  

Investments
 4 
6,257,608
5,740,472

  
6,257,608
5,740,472

Current assets
  

Debtors: amounts falling due within one year
 5 
18,815
19,062

Cash at bank and in hand
 6 
317,251
321,888

  
336,066
340,950

Creditors: amounts falling due within one year
 7 
(6,251,836)
(6,036,823)

Net current liabilities
  
 
 
(5,915,770)
 
 
(5,695,873)

Total assets less current liabilities
  
341,838
44,599

  

Net assets
  
341,838
44,599


Capital and reserves
  

Called up share capital 
 8 
100
100

Profit and loss account
  
341,738
44,499

  
341,838
44,599


The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.   

Page 1

 
NEUCLIB LIMITED
REGISTERED NUMBER: 11963976
    
BALANCE SHEET (CONTINUED)
AS AT 31 DECEMBER 2024

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 17 July 2025.




................................................
M Pasanisi
Director

The notes on pages 3 to 6 form part of these financial statements.

Page 2

 
NEUCLIB LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

1.


General information

Neuclib Limited is a private company limited by shares and incorporated in England and Wales. Its registered office is Calder & Co, 30 Orange Street, London, WC2H 7HF.
The accounts are presented in GBP which is functional currency of the company.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The following principal accounting policies have been applied:

 
2.2

Foreign currency translation

Functional and presentation currency

The Company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss except when deferred in other comprehensive income as qualifying cash flow hedges.

Foreign exchange gains and losses that relate to borrowings and cash and cash equivalents are presented in the Statement of income and retained earnings within 'finance income or costs'. All other foreign exchange gains and losses are presented in profit or loss within 'other operating income'.

 
2.3

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.4

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

Page 3

 
NEUCLIB LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

 
2.5

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

 
2.6

Valuation of investments

Investments in unlisted Company shares, whose market value can be reliably determined, are remeasured to market value at each balance sheet date. Gains and losses on remeasurement are recognised in the Statement of income and retained earnings for the period. Where market value cannot be reliably determined, such investments are stated at historic cost less impairment.

 
2.7

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.8

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.9

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.10

Financial instruments

The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.

Debt instruments (other than those wholly repayable or receivable within one year), including loans and other accounts receivable and payable, are initially measured at present value of the future cash flows and subsequently at amortised cost using the effective interest method. Debt instruments that are payable or receivable within one year, typically trade debtors and creditors, are measured, initially and subsequently, at the undiscounted amount of the cash or other consideration expected to be paid or received. However, if the arrangements of a short-term instrument constitute a financing transaction, like the payment of a trade debt deferred beyond normal business terms or in case of an out-right short-term loan that is not at market rate, the financial asset or liability is measured, initially at the present value of future cash flows discounted at a market rate of interest for a similar debt instrument and subsequently at amortised cost, unless it qualifies as a loan from a director in the case of a small company, or a public benefit entity concessionary loan.
Page 4

 
NEUCLIB LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)


2.10
Financial instruments (continued)


For financial assets measured at cost less impairment, the impairment loss is measured as the difference between an asset's carrying amount and best estimate of the recoverable amount, which is an approximation of the amount that the Company would receive for the asset if it were to be sold at the balance sheet date.


3.


Employees

The average monthly number of employees, including directors, during the year was 1 (2023 - 1).


4.


Fixed asset investments





Listed investments

£



Cost or valuation


At 1 January 2024
5,740,472


Additions
832,579


Disposals
(415,556)


Revaluations
100,113



At 31 December 2024
6,257,608





5.


Debtors

2024
2023
£
£


Other debtors
18,815
19,062

18,815
19,062


Page 5

 
NEUCLIB LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

6.


Cash and cash equivalents

2024
2023
£
£

Cash at bank and in hand
317,251
321,888

317,251
321,888



7.


Creditors: Amounts falling due within one year

2024
2023
£
£

Corporation tax
37,632
22,560

Other creditors
6,210,604
6,010,663

Accruals and deferred income
3,600
3,600

6,251,836
6,036,823



8.


Share capital

2024
2023
£
£
Allotted, called up and fully paid



100 (2023 - 100) Ordinary shares of £1.00 each
100
100



9.


Related party transactions

As at 31 December 2024 the company owed its director £4,277,400 (2023: £4,010,662) by virtue of a directors current account. This amount is interest free and has no fixed repayment terms.

 
Page 6